See What HealthDay Can Do For You
Contact Us

FDA Approves New Drug-Eluting Stent

To help people with narrowed arteries

FRIDAY, Feb. 1, 2008 (HealthDay News) -- A new drug-coated stent has been approved the U.S. Food and Drug Administration to treat people with narrowed arteries that supply blood to the heart.

A stent is a wire mesh tube used to keep an artery propped open once it has been cleared of a blockage. The device is sometimes coated with a drug designed to help prevent an artery from reclogging, a process call restenosis. This device's new drug, zotarolimus, was developed only for use on a stent.

The Endeavor Zotarolimus-Eluting Coronary Stent is the first drug-eluting stent approved by the FDA since 2004, the agency said in a statement. Drug-coated stents have come under scrutiny recently over concerns that users may be at greater risk of a rare blood clot known as a stent thrombosis.

The maker of the Endeavor device, Minneapolis-based Medtronic Inc., conducted seven clinical trials of the device, in which the company said it was shown to significantly reduce the number of major coronary events -- including heart attack, cardiac death and surgical procedures to reopen stented arteries compared to a bare-metal stent.

Medtronic will follow patients who participated in clinical testing for five years, the FDA said. The company also will conduct a 2,000 patient post-approval study to evaluate the long-term safety and effectiveness of the device.

More information

The FDA has more about this approval.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.